What it is
Summary
AI-generated from vendor-published content
The iPad Pro is a tablet computer with a large touchscreen and powerful processor. It's an AT platform — meaning it can run thousands of accessibility apps and has built-in features like screen readers, magnification, voice control, and switch access. People with disabilities use iPad Pro as the foundation for communication, learning, vision support, and motor control.
Quick Facts Catalog facts · auto-generated
- Insurance
- Out of pocket
- School district
- Vocational rehab
What Setup Looks Like
- Out of the box, the iPad Pro works as a standard tablet — turn it on, connect to Wi-Fi, and sign in with an Apple ID.
- Accessibility features are built in and ready to enable in Settings > Accessibility — this takes about 10 minutes and requires no special equipment.
- If you want to use specialized apps (like AAC software, eye-gaze control, or switch access), you'll install them from the App Store.
- For complex setups — like calibrating eye gaze, programming switch-accessible games, or customizing AAC vocabulary — a speech therapist, occupational therapist, or AT specialist should help.
- Most schools and therapy clinics have staff who can do this.
Getting it
Many states lend devices like this for free trial periods — find your state's AT lending program.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from Apple — view on vendor site; last verified June 18, 2026.
Classification & description AI-generated from vendor-published content · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.